Compounds having ((3-nitrophenyl)sulfonyl)acetamide as BCL-2 inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11834450
APP PUB NO 20220306625A1
SERIAL NO

17698956

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is generally directed to inhibitors of BCL-2 proteins useful in the treatment of diseases and disorders modulated by said enzyme and having the Formula (I):

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • EIL THERAPEUTICS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Abagyan, Ruben La Jolla, US 10 47
Ivachtchenko, Alexandre Vasilievich Hallandale Beach, US 42 128
Kysil, Volodymyr San Diego, US 5 7
Lam, Polo Chun-Hung San Diego, US 4 0
Orry, Andrew San Diego, US 4 0
Parchinsky, Vladislav Zenonovich Moscow, RU 4 0
Pushechnikov, Alexei San Diego, US 7 0
Savchuk, Nikolay San Diego, US 6 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jun 5, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 5, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 5, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00